Sunday, May 13, 2012 - 08:00 to 09:15
May 13 - 18
Speke Resort & Conference Centre
Part of the Keystone Symposia Global Health Series, Supported by the Bill & Melinda Gates Foundation. ponsored by GlaxoSmithKline
Organizers: Ann M. Ginsberg and John D. McKinney
The Keystone Symposia meeting on Drug Resistance and Persistence in Tuberculosis aims to bring together basic and clinical researchers and public health experts from diverse backgrounds to explore the following: 1) the fundamental biology underlying genetic and phenotypic drug-resistance in TB; 2) progress in expanding capacity in high-burden settings to perform drug susceptibility testing; 3) identification of novel drug targets; 4) innovative strategies for drug discovery; and 5) advances in developing multi-drug regimens that will be effective against currently drug-resistant as well as drug-sensitive strains of M. tuberculosis. Investigators from outside the TB field will be included to provide new perspectives and stimulate fresh approaches for tackling this global public health priority.
More information: http://www.keystonesymposia.org/meetings/viewMeetings.cfm?MeetingID=1165